Pharmaceutical and biotechnology major Wockhardt today, November 13, announced the launch of Midazolam injection in the United States. Wockhardt received this approval from the United States Food and Drug Administration (US FDA) for marketing the preservative free version injections containing 1 mg/ml and 5mg/ml.   read more »